Cargando…
Development of Pigmentation-Regulating Agents by Drug Repositioning
Skin color is determined by the processes of melanin synthesis and distribution. Problems in various molecules or signaling pathways involved in melanin synthesis contribute to skin pigmentation defects. Several trials have been conducted on the production of pigmentation-regulating agents, and drug...
Autores principales: | Jeong, Seo-Mi-Gon, Yoon, Tae-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069425/ https://www.ncbi.nlm.nih.gov/pubmed/33918792 http://dx.doi.org/10.3390/ijms22083894 |
Ejemplares similares
-
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022) -
Knowledge Mapping of Drug Repositioning’s Theme and Development
por: Lang, Xiaona, et al.
Publicado: (2023) -
Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2020) -
Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012) -
Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)